172 related articles for article (PubMed ID: 1446708)
41. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit.
Stok W; van der Heijden PJ; Bianchi AT
Vaccine; 1994 May; 12(6):521-6. PubMed ID: 8036826
[TBL] [Abstract][Full Text] [Related]
42. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
Vaccine; 1994 Oct; 12(13):1238-40. PubMed ID: 7839730
[TBL] [Abstract][Full Text] [Related]
43. Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.
Yoshikawa T; Uchida T; Naito S; Horino A; Taneichi M; Kato H; Komuro K; Nakano Y; Mori M; Nishinohara S; Chiba J; Kurata T; Tamura S
Int Arch Allergy Immunol; 2000 Feb; 121(2):108-15. PubMed ID: 10705220
[TBL] [Abstract][Full Text] [Related]
44. Low-dose oral tolerance due to antigen in the diet suppresses differentially the cholera toxin-adjuvantized IgE, IgA and IgG response.
Christensen HR; Kjaer TM; Frøkiaer H
Int Arch Allergy Immunol; 2003 Nov; 132(3):248-57. PubMed ID: 14646386
[TBL] [Abstract][Full Text] [Related]
45. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
Bowen JC; Nair SK; Reddy R; Rouse BT
Immunology; 1994 Mar; 81(3):338-42. PubMed ID: 8206507
[TBL] [Abstract][Full Text] [Related]
46. Oral tolerance to ovalbumin in mice: induction and long-term persistence unaffected by Staphylococcus aureus enterotoxin B and Clostridium perfringens type A enterotoxin.
Gaboriau-Routhiau V; Moreau MC
Pediatr Res; 1997 Oct; 42(4):503-8. PubMed ID: 9380444
[TBL] [Abstract][Full Text] [Related]
47. Effects of diphenyl dimethyl dicarboxylate on oral tolerance to ovalbumin in mice.
Kim JH; Ahn YK
J Toxicol Sci; 1995 Sep; 20(4):375-82. PubMed ID: 8531232
[TBL] [Abstract][Full Text] [Related]
48. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
Sun JB; Flach CF; Czerkinsky C; Holmgren J
J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
[TBL] [Abstract][Full Text] [Related]
49. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
Elson CO; Ealding W
J Immunol; 1984 Dec; 133(6):2892-7. PubMed ID: 6491278
[TBL] [Abstract][Full Text] [Related]
50. A genetically determined lack of oral tolerance to ovalbumin is due to failure of the immune system to respond to intestinally derived tolerogen.
Mowat AM; Lamont AG; Bruce MG
Eur J Immunol; 1987 Nov; 17(11):1673-6. PubMed ID: 3678362
[TBL] [Abstract][Full Text] [Related]
51. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
[TBL] [Abstract][Full Text] [Related]
52. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
[TBL] [Abstract][Full Text] [Related]
53. Aminoguanidine administered during the induction of oral tolerance alters the systemic response of the tolerised rats.
Franco LG; Feledi CA; Massouh EJ; Benencia F
Cell Immunol; 2010; 261(1):42-50. PubMed ID: 19931043
[TBL] [Abstract][Full Text] [Related]
54. Abrogation of the oral tolerance to ovalbumin in mice by citrus pectin.
Khramova DS; Popov SV; Golovchenko VV; Vityazev FV; Paderin NM; Ovodov YS
Nutrition; 2009 Feb; 25(2):226-32. PubMed ID: 18947979
[TBL] [Abstract][Full Text] [Related]
55. Flagellin produced in plants is a potent adjuvant for oral immunization.
Girard A; Saron W; Bergeron-Sandoval LP; Sarhan F; Archambault D
Vaccine; 2011 Sep; 29(38):6695-703. PubMed ID: 21745522
[TBL] [Abstract][Full Text] [Related]
56. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
Grdic D; Smith R; Donachie A; Kjerrulf M; Hörnquist E; Mowat A; Lycke N
Eur J Immunol; 1999 Jun; 29(6):1774-84. PubMed ID: 10382739
[TBL] [Abstract][Full Text] [Related]
57. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
[TBL] [Abstract][Full Text] [Related]
58. The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice.
Dong H; Huang Y; Yao S; Liang B; Long Y; Xie Y; Mai J; Gong S; Zhou Z
Appl Microbiol Biotechnol; 2017 Jul; 101(14):5819-5829. PubMed ID: 28608279
[TBL] [Abstract][Full Text] [Related]
59. Oral exposure to drugs with immune-adjuvant potential induces hypersensitivity responses to the reporter antigen TNP-OVA.
Kwast LM; Fiechter D; Hassing I; Bleumink R; Boon L; Ludwig IS; Pieters RH
Toxicol Sci; 2011 Jun; 121(2):312-9. PubMed ID: 21402728
[TBL] [Abstract][Full Text] [Related]
60. The identification of plant lectins with mucosal adjuvant activity.
Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT
Immunology; 2001 Jan; 102(1):77-86. PubMed ID: 11168640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
